ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment
The Journal of Clinical Pharmacology
◽
10.1002/jcph.590
◽
2015
◽
Vol 56
(3)
◽
pp. 316-323
◽
Cited By ~ 4
Author(s):
Denes Csonka
◽
Katharine Hazell
◽
Edward Waldron
◽
Sebastien Lorenzo
◽
Vincent Duval
◽
...
Keyword(s):
Single Dose
◽
Hepatic Impairment
◽
Phase 1
◽
Severe Hepatic Impairment
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
Related Documents
Cited By
References
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
Leukemia & Lymphoma
◽
10.1080/10428194.2020.1719097
◽
2020
◽
Vol 61
(6)
◽
pp. 1355-1363
Author(s):
Ying C. Ou
◽
Richard A. Preston
◽
Thomas C. Marbury
◽
Zhiyu Tang
◽
William Novotny
◽
...
Keyword(s):
Single Dose
◽
Hepatic Impairment
◽
Phase 1
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study
Clinical Pharmacology in Drug Development
◽
10.1002/cpdd.234
◽
2016
◽
Vol 5
(3)
◽
pp. 180-187
Author(s):
Ajit Suri
◽
Sandeepraj Pusalkar
◽
Yuexian Li
◽
Shimoga Prakash
Keyword(s):
Single Dose
◽
Phase 1
◽
Healthy Male
◽
Open Label
◽
Single Dose Study
◽
Investigational Agent
◽
Dose Study
◽
Male Subjects
Download Full-text
Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
Clinical Therapeutics
◽
10.1016/j.clinthera.2011.09.011
◽
2011
◽
Vol 33
(11)
◽
pp. 1798-1808
◽
Cited By ~ 47
Author(s):
Sreeneeranj Kasichayanula
◽
Xiaoni Liu
◽
Weijiang Zhang
◽
Marc Pfister
◽
Frank P. LaCreta
◽
...
Keyword(s):
Single Dose
◽
Safety Profile
◽
Hepatic Impairment
◽
Open Label
◽
Single Dose Study
◽
Parallel Group
◽
Dose Study
Download Full-text
An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis
International Journal of Antimicrobial Agents
◽
10.1016/j.ijantimicag.2015.09.009
◽
2015
◽
Vol 46
(6)
◽
pp. 682-688
◽
Cited By ~ 2
Author(s):
Maria Sunzel
◽
Maria Learoyd
◽
Jianguo Li
◽
Yan Li
◽
Ngoc Ngo
◽
...
Keyword(s):
Single Dose
◽
Renal Disease
◽
End Stage Renal Disease
◽
Phase 1
◽
Open Label
◽
Single Dose Study
◽
Intermittent Haemodialysis
◽
Dose Study
◽
Stage Renal Disease
◽
End Stage
Download Full-text
A phase 1, randomised, open-label, four-period crossover, single-dose study to evaluate the pharmacokinetics of hydrocortisone modified release tablets
Endocrine Abstracts
◽
10.1530/endoabs.37.ep54
◽
2015
◽
Author(s):
Gudmundur Johannsson
◽
Hans Lennernas
◽
Claudio Marelli
◽
Kevin Rockich
◽
Stanko Skrtic
Keyword(s):
Single Dose
◽
Phase 1
◽
Modified Release
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed-dose combination compared with individual components: A phase 1, open-label, single-dose study
Clinical Pharmacology in Drug Development
◽
10.1002/cpdd.209
◽
2015
◽
Vol 5
(2)
◽
pp. 109-117
◽
Cited By ~ 6
Author(s):
Rainard Fuhr
◽
Anne Leselbaum
◽
Jordi Aubets
Keyword(s):
Single Dose
◽
Phase 1
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Open Label
◽
Single Dose Study
◽
Dose Study
◽
Aclidinium Bromide
◽
Dose Combination
◽
Formoterol Fumarate
Download Full-text
A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
The Journal of Clinical Pharmacology
◽
10.1002/jcph.1412
◽
2019
◽
Vol 59
(8)
◽
pp. 1110-1119
◽
Cited By ~ 21
Author(s):
Lesley Taylor
◽
Julie Crockett
◽
Bola Tayo
◽
Gilmour Morrison
Keyword(s):
Single Dose
◽
Hepatic Impairment
◽
Phase 1
◽
Severe Hepatic Impairment
◽
Open Label
◽
Parallel Group
◽
Dose Trial
Download Full-text
Single-center, phase i, open label, single dose study to evaluate the pharmacokinetics and safety of wck 2349 in patients with hepatic impairment
10.26226/morressier.56d6be7ad462b80296c97cf9
◽
2016
◽
Author(s):
Richard Preston
Keyword(s):
Single Dose
◽
Phase I
◽
Hepatic Impairment
◽
Single Center
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
1027-P: A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment
Diabetes
◽
10.2337/db19-1027-p
◽
2019
◽
Vol 68
(Supplement 1)
◽
pp. 1027-P
Author(s):
GERNOT K. KLEIN
◽
MARCELLA PETRONE
◽
YE YANG
◽
THUONG HOANG
◽
SHEILA DICOSTANZA
◽
...
Keyword(s):
Single Dose
◽
Renal Impairment
◽
Phase 1
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
An open-label, single-dose study to assess the effect of hepatic impairment on the pharmacokinetics of mirogabalin
Journal of Pain
◽
10.1016/j.jpain.2017.12.168
◽
2018
◽
Vol 19
(3)
◽
pp. S74
Author(s):
K. Duchin
◽
G. Senaldi
◽
V. Warren
◽
J. Lee
◽
T. Marbury
◽
...
Keyword(s):
Single Dose
◽
Hepatic Impairment
◽
Open Label
◽
Single Dose Study
◽
Dose Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close